QT Medical
Developer of ECG devices and cardiac health monitoring tools. Developer of ECG devices and cardiac health monitoring tools. The company has developed QT ECG, which is a portable 12-lead smart ECG device that can transfer data to the mobile app. It can be used by patients for home use to monitor and share the heart health of patients with chronic heart failure and arrhythmias. Founded in 2013, headquartered in…
Funding snapshot
About
Developer of ECG devices and cardiac health monitoring tools. Developer of ECG devices and cardiac health monitoring tools. The company has developed QT ECG, which is a portable 12-lead smart ECG device that can transfer data to the mobile app. It can be used by patients for home use to monitor and share the heart health of patients with chronic heart failure and arrhythmias. Founded in 2013, headquartered in Torrance, United States. The company operates in the Life Sciences > Cardiac and Vascular Disorders, HealthTech > Healthcare IT sector. Founded in 2013 and headquartered in Torrance, United States and has raised $12.0 million in Series B funding. Key investors include CDIB Capital, Cathay Capital, Taiwania Capital, BE Capital, Tmubiomedaccelerator, Quanta Computer, HHS.
Business model
Wearable Technology > Smart Clothing and Accessories > Smart Bras > Cardiac Monitoring,
Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > Device,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Cardiology > Tele ECG,
Cardiac and Vascular Disorders > Medical Devices > Screening Devices > Cardiac Diagnostic > Electrodiagnostic Testing (ECG) > Home Based
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.